Clinical Trial Update: Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing rapid infusion of intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency
• Common Variable Immunodeficiency
• Immunodeficiency Disease
• Wiskott-aldrich Syndrome
• X-linked Agammaglobulinemia

Drugs mentioned

• Intravenous immunoglobulin (human) (intravenous immunoglobulin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Immunologic Deficiency Syndrome, Agammaglobulinemia | Phase 3 | Status: COMPLETED